LivaNova (LIVN) EBITDA Margin (2014 - 2026)
LivaNova recorded quarterly EBITDA Margin of 11.45% in Q1 2026, down 2.96% quarter-over-quarter from 11.8% in Q4 2025, and down 390.0% year-over-year from 3.95% in Q1 2025.
LivaNova's EBITDA Margin history runs 13 years deep, the most recent figure standing at 11.45% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 390.0% year-over-year to 11.45%; the TTM figure through Mar 2026 stood at 13.41% (up 75.0% YoY), while the FY2025 annual figure was 14.36%, up 407.0% from the prior year.
- EBITDA Margin came in at 11.45% for Q1 2026 at LivaNova, down from 11.8% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 15.37% in Q2 2025 to a low of 52.24% in Q3 2022.
- A 5-year average of 3.37% and a median of 11.2% in 2024 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin plunged 5873 bps in 2022 and jumped 5380 bps in 2023, its largest moves.
- LivaNova's EBITDA Margin stood at 5.08% in 2022, then plunged by 659 bps to 28.37% in 2023, then surged by 141 bps to 11.5% in 2024, then gained by 3 bps to 11.8% in 2025, then decreased by 3 bps to 11.45% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 11.45%, 11.8%, and 15.1% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 11.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.45% |
| Dec 31, 2025 | 11.80% |
| Sep 30, 2025 | 15.10% |
| Jun 30, 2025 | 15.37% |
| Mar 31, 2025 | 15.34% |
| Dec 31, 2024 | 11.50% |
| Sep 30, 2024 | 11.20% |
| Jun 30, 2024 | 12.61% |
| Mar 31, 2024 | 5.51% |
| Dec 31, 2023 | -28.37% |
| Sep 30, 2023 | 1.56% |
| Jun 30, 2023 | 5.91% |
| Mar 31, 2023 | -0.89% |
| Dec 31, 2022 | 5.08% |
| Sep 30, 2022 | -52.24% |
| Jun 30, 2022 | 12.49% |
| Mar 31, 2022 | 3.96% |
| Dec 31, 2021 | 9.17% |
| Sep 30, 2021 | 6.49% |
| Jun 30, 2021 | -13.71% |
| Mar 31, 2021 | -2.30% |
| Dec 31, 2020 | -92.38% |
| Sep 30, 2020 | -3.15% |
| Jun 30, 2020 | -9.19% |
| Mar 31, 2020 | -0.24% |
| Dec 31, 2019 | -50.06% |
| Sep 30, 2019 | 9.59% |
| Jun 30, 2019 | -10.78% |
| Mar 31, 2019 | -8.29% |
| Dec 31, 2018 | -93.09% |
| Sep 30, 2018 | -2.12% |
| Jun 30, 2018 | 7.52% |
| Mar 31, 2018 | 5.00% |
| Dec 31, 2017 | 6.81% |
| Sep 30, 2017 | 11.95% |
| Jun 30, 2017 | 10.86% |
| Mar 31, 2017 | 8.71% |
| Dec 31, 2016 | -5.96% |
| Sep 30, 2016 | 12.74% |
| Jun 30, 2016 | 9.95% |
| Mar 31, 2016 | -4.03% |
| Oct 18, 2015 | -39.03% |
| Jul 24, 2015 | 26.25% |
| Apr 24, 2015 | 22.57% |
| Oct 24, 2014 | 35.77% |